Patent Attorney Overcomes Canva’s Sanctions Bid, Highlighting Challenges in Tech Litigation

In a significant legal development, a well-regarded patent attorney has successfully fended off a second sanctions request from Canva, the widely used online design platform. The attorney, known for their extensive experience in patent law, faced allegations from Canva, which were ultimately dismissed by the court. This victory highlights the complexities associated with patent litigation,…

Read More

Pillsbury Winthrop Shaw Pittman’s Strategic Recruitment of Michael Vetesi Boosts West Coast Intellectual Property Practice

Pillsbury Winthrop Shaw Pittman LLP has recently made a strategic move by recruiting Michael Vetesi from Morrison Foerster to enhance its intellectual property practice in San Francisco. This decision is seen as part of Pillsbury’s efforts to bolster its IP capabilities on the West Coast. Vetesi, who has a substantial background in IP litigation, brings…

Read More

Dropbox Successfully Sidesteps Patent Infringement Trial in Cloud Storage Technology Dispute

Dropbox Inc. has successfully avoided a scheduled trial in a patent infringement case brought by Entangled Media, LLC, concerning cloud-based data storage technology. The trial, initially set for September 8, 2026, was called off after a California federal judge determined that Entangled Media could not substantiate claims of infringement under an alternative theory, following a…

Read More

Lyft Ordered to Pay $1 Million After Texas Court Upholds Patent Infringement Verdict

In a recent legal development, U.S. District Judge Alan Albright upheld a $1 million verdict against Lyft Inc. for patent infringement involving ride-hailing technology owned by Quartz Auto Technologies LLC. The case, heard in a Texas federal court, concluded with the jury determining that Lyft had indeed utilized technology covered under Quartz Auto’s patent without…

Read More

Delaware Court Clears Lupin to Launch Generic Cystic Fibrosis Drug in Landmark Patent Case

In a significant development for the pharmaceutical industry, a Delaware federal court recently ruled in favor of Lupin Ltd. in a patent infringement lawsuit brought by Vertex Pharmaceuticals Inc. The case centered on Vertex’s allegations that Lupin’s planned generic version of a cystic fibrosis treatment violated patents held by Vertex. The court found that Lupin’s…

Read More

D.C. Circuit Court Orders FDA to Reassess Generic Drug Exclusivity in Landmark Xifaxan Ruling

In a significant ruling on Tuesday, the D.C. Circuit Court called on the U.S. Food and Drug Administration (FDA) to reassess the conditions for issuing generic exclusivity concerning Xifaxan, a widely used medication for treating irritable bowel syndrome. The decision, critical of the FDA’s previously employed causation standard, reflects ongoing tensions between brand-name and generic…

Read More

Challenges and Debates Surrounding “Plain Meaning” in Intellectual Property Litigation

The concept of “plain meaning” in intellectual property litigation has recently garnered attention with calls for a more precise application. The principle generally refers to interpreting statutory text by its ordinary meaning as understood by a typical person. However, legal experts argue that this interpretation often lacks clarity, resulting in inconsistent court decisions. A recent…

Read More

USPTO’s Proposed Rule Calls for Greater Transparency in Patent Reexaminations

The United States Patent and Trademark Office (USPTO) has proposed a rule that would require third-party requesters of ex parte reexaminations to disclose all real parties in interest (RPI) to the Office. This proposal, published on July 22, 2026, aims to enhance transparency and ensure compliance with statutory estoppel provisions established under the America Invents…

Read More

Delaware Judge Partially Upholds Infringement Findings Against NuVasive in Spinal Implant Patent Case

A Delaware federal judge has maintained most of the jury’s findings of infringement against NuVasive in a pivotal case involving spinal implant patents. However, the judge determined that some of the jury’s conclusions lacked sufficient supporting evidence. This outcome reflects a nuanced landscape in intellectual property litigation, balancing patent protection with thorough evidentiary standards. For…

Read More

Federal Circuit Expedites Key Patent Dispute Over COVID-19 Vaccine Innovations Involving Moderna and Arbutus Biopharma

The Federal Circuit has agreed to expedite proceedings in a contentious patent case concerning COVID-19 vaccines, involving biotechnology giants Moderna Inc. and Arbutus Biopharma Corp. The accelerated timeline means that oral arguments will happen in November, a decision that reflects the ongoing sensitivity and urgency of patent disputes in the realm of pandemic-related innovations. The…

Read More

Judge Increases Guardant Health’s Damages to TwinStrand Biosciences to $245 Million in Patent Infringement Case

In a significant development in the biotech industry, a judge has increased the damages owed by Guardant Health Inc. to TwinStrand Biosciences, Inc., bringing the total to $245 million. This ruling follows a decision that found Guardant had infringed two patents held by TwinStrand concerning techniques aimed at reducing errors in DNA sequencing. The ruling…

Read More

Federal Judge Overturns Immigration Visa Ban Affecting 75 Countries, Citing Overreach by State Department

In a significant legal decision, the US District Court for the Southern District of New York invalidated a controversial ban that affected immigrant visas for residents of 75 countries. Judge Jeannette Vargas declared that Secretary of State Marco Rubio’s directive was “patently unlawful,” asserting that it exceeded the authority granted to him under the Immigration…

Read More

Cytek Biosciences Faces $36 Million Penalty for Patent Infringement on Beckman Coulter’s Cell-Sorting Technology

In a significant development for the biotechnology sector, Cytek Biosciences has been ordered by a Delaware federal jury to pay approximately $36 million in damages for patent infringement. The jury found that Cytek had violated a patent held by Beckman Coulter, which relates to technology critical for the rapid analysis of single cells. This decision…

Read More

Dish and Sling Sue Gaia Over Patent Infringement in Streaming Technology Dispute

Dish Technologies LLC and Sling TV LLC have filed a lawsuit against Gaia Inc., a streaming company based in Colorado, citing infringement of five patents related to content streaming. The lawsuit, filed in a Colorado federal court, alleges that Gaia’s streaming services infringe on proprietary technologies designed to adapt streaming based on users’ bandwidth availability….

Read More

Andrew Robb Secures Major Legal Victory in Verizon Patent Infringement Case, Overturning $847 Million Verdict

In a notable legal triumph, Andrew Robb of Gibson, Dunn & Crutcher LLP has successfully navigated the complexities of a high-profile patent infringement case, overturning an $847 million verdict against Verizon. This decision marks one of the significant recent developments in intellectual property litigation. For seasoned legal professionals and observers of corporate law, Robb’s achievement…

Read More

FTC Challenges Amgen’s Patent Acquisition Strategy in High-Stakes Antitrust Appeal

In a significant legal confrontation, the Federal Trade Commission (FTC) has called on the Fourth Circuit to dismiss Amgen Inc.’s argument that commercial agreements for acquiring patent rights are inherently immune to antitrust reviews. This legal dispute arises amidst an appeal concerning Enbrel, Amgen’s highly successful autoimmune medication. The FTC contends that Amgen’s stance poses…

Read More

USPTO Defends “Settled Expectations” Policy Against Google’s Challenge at Federal Circuit

The U.S. Patent and Trademark Office (USPTO) has recently defended its “settled expectations” policy before the Federal Circuit, urging the court to reject Google’s constitutional challenge to this approach. The policy allows the USPTO to consider the age of a patent when deciding whether to institute inter partes review (IPR) proceedings, with the agency asserting…

Read More

Florida Court Dismisses Patent Dispute for Lack of Demonstrable Harm, Setting Important Precedent

In a recent development within the realm of intellectual property law, a Florida federal judge has dismissed a lawsuit regarding a patent dispute over a sports scoring system. The plaintiff had alleged that his co-inventor conspired to exclude him from the patent’s inventorship, but the court found that there were no demonstrable consequences resulting from…

Read More

USPTO’s Strategic Move in Patent Litigation: A New Chapter in Tech Innovation Disputes

U.S. Patent and Trademark Office Director John Squires recently issued an order addressing a series of America Invents Act proceedings, where he instituted two petitions and refrained from denying any, marking a strategic direction in patent litigation. Among the cases is a notable challenge by Google against a patent held by Valtrus Innovations. This action…

Read More

Irish Patent Holders Sue Sabey Data Center for Alleged Cooling Technology Infringement

Two Irish patent-holding companies have initiated a legal battle against Sabey Data Center Properties LLC, alleging infringement of their patented data center cooling technology. Filed in Virginia federal court, the case highlights ongoing challenges in the tech industry over intellectual property rights reported Law360. The complaint focuses on specific technologies utilized by Sabey within its…

Read More

Rising Data Center Legal Disputes Highlight IP Challenges in Tech Expansion

The rapid expansion of data centers worldwide has led to a noteworthy increase in legal disputes revolving around patents and trade secrets. Companies are vying to protect proprietary technologies that enhance efficiency, security, and cooling systems, vital to the operation of these data hubs. As these tasks become increasingly complex, the opportunity for conflict over…

Read More

Federal Circuit Review Poised to Clarify Obviousness-Type Double Patenting Discrepancies

The intricate doctrine of obviousness-type double patenting is currently poised for potential clarification by the Federal Circuit. This intricacy has been amplified by a recent decision juxtaposed with a brief from the U.S. Patent and Trademark Office (USPTO), each appearing to diverge on a critical aspect of the doctrine. This scenario could prompt the Federal…

Read More